1/4
Export Ready

VIREAD 300MG

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Product details

What are the specifications of this product?

Overview

Product Name: VIREAD® 300mg Tablet Manufacturer: Gilead Sciences Composition (per tablet): • Tenofovir Disoproxil Fumarate (TDF) 300 mg Therapeutic Category: Antiviral / Antiretroviral Product Description: VIREAD® 300mg is an antiretroviral medicine containing Tenofovir Disoproxil Fumarate (TDF), a nucleotide reverse transcriptase inhibitor (NtRTI). It is used in the treatment of HIV-1 infection and chronic hepatitis B virus (HBV) infection. It helps lower viral load, improves immune function, and reduces liver-related complications in HBV patients. VIREAD is often used as part of combination therapy in HIV treatment. Indications: • HIV-1 infection (in combination with other antiretroviral agents) • Chronic Hepatitis B infection in adults and adolescents Mechanism of Action: • Tenofovir inhibits the activity of reverse transcriptase, blocking viral DNA replication. • This prevents multiplication of HIV and HBV in the body. Dosage & Administration: • Usual adult dose: 1 tablet (300mg) once daily, with or without food. • Dose adjustment required in patients with renal impairment.

Product Description

Key Benefits:

• Effective in suppressing HIV viral load.

• Reduces liver inflammation and viral activity in HBV.

• Once-daily convenient oral therapy.


Packaging:

• Bottles of 30 film-coated tablets.


Storage:

• Store below 30°C, tightly closed.

• Protect from moisture.

• Keep out of reach of children.


Important Notes:

• For use under medical supervision only.

• Not a cure for HIV/AIDS or HBV, but controls viral replication.

• Long-term therapy may affect bone density and kidney function—regular monitoring is advised.


ONCOLOGY EXPORTERS FROM INDIA

Melizza Lifescience

Description provided by melizza lifescience.

Specifications

Manufacturer Gilead Sciences
Composition per Tablet Tenofovir Disoproxil Fumarate (TDF) 300 mg
Form Film-coated tablet
Administration Route Oral
Patient Group Adults and adolescents with HIV-1 or chronic HBV infection
Storage Temperature Below 30°C
Pack Size 30 tablets per bottle
Renal Impairment Dose Adjustment Required
Therapy Type Combination therapy for HIV; monotherapy/combination for HBV
Safety Note Use under medical supervision required
Shelf Life As indicated on packaging (not specified)

Use cases

Category Pharmaceuticals > Antiretroviral Drugs > Tenofovir Products
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form Film-coated tablet

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing VIREAD 300MG. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is VIREAD 300mg suitable for monotherapy in chronic Hepatitis B?
A: Yes, VIREAD 300mg can be used as monotherapy for chronic Hepatitis B infection in adults and adolescents; however, HIV co-infection must be ruled out before initiation.
Q: What dose adjustment is required for patients with renal impairment?
A: Dose adjustment of VIREAD 300mg tablets is required in patients with impaired renal function. It is important to monitor kidney function regularly and consult a physician for appropriate dosage modifications.
Q: Can VIREAD 300mg be taken with food?
A: Yes, VIREAD 300mg tablets can be administered with or without food without affecting its efficacy.
Q: Does long-term use of VIREAD 300mg affect bone density?
A: Long-term therapy with VIREAD 300mg may reduce bone mineral density; therefore, regular monitoring is advised during prolonged treatment.
Q: Is VIREAD a cure for HIV or HBV infection?
A: No, VIREAD does not cure HIV or HBV infections but controls viral replication and improves clinical outcomes when used as part of combination therapy.
Q: What is the packaging format for VIREAD 300mg tablets?
A: VIREAD 300mg is supplied in bottles containing 30 film-coated tablets.
Question not answered? Ask sellers directly — typical response within 4 hours.
VIREAD 300MG
VIREAD 300MG
Price on request · MOQ 1Centimetre